Abstract
Background: After the spread of novel coronavirus disease 2019 (COVID-19) from Wuhan to Iran, gastroenterology clinics, was faced with a large number of patients who were suspected of being infected with the SARS-CoV-2. Among refereed patient, the incidence of pure hyperbilirubinemia as rare gastrointestinal (GI) symptoms was obvious.
Methods: In this case series, we have reported the clinical data in details for patients with COVID-19 who have been admitted to the Shahid Beheshti Hospital in Qom city, from 3 March to 3 August 2020. COVID infection, be confirmed by using real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) and chest computed tomography (CT) scan, as well.
Results: According to the clinical findings, pure hyperbilirubinemia may consider as rare gastrointestinal (GI) symptom of COVID-19. However, it is possible that the other GI enzymes values fall in to the normal range.
Conclusion: In some infected patients, GI physicians may face hepatic involvement as pure hyperbilirubinemia. At the age of COVID-19 crisis, all GI physicians should be aware of the possible occurrence of hepatic involvement as an important prognosis of COVID pneumonia and it should be exactly addressed in new referred patients to GI clinic.
Keywords: COVID-19, rRT-PCR, hyperbilirubinemia, CT, scan, gastrointestinal, symptom, GI enzyme.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran
Volume: 21 Issue: 8
Author(s): Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian and Sajjad Ahmadpour*
Affiliation:
- Assistant Professor of Nuclear Pharmacy, Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, ,Iran
Keywords: COVID-19, rRT-PCR, hyperbilirubinemia, CT, scan, gastrointestinal, symptom, GI enzyme.
Abstract: Background: After the spread of novel coronavirus disease 2019 (COVID-19) from Wuhan to Iran, gastroenterology clinics, was faced with a large number of patients who were suspected of being infected with the SARS-CoV-2. Among refereed patient, the incidence of pure hyperbilirubinemia as rare gastrointestinal (GI) symptoms was obvious.
Methods: In this case series, we have reported the clinical data in details for patients with COVID-19 who have been admitted to the Shahid Beheshti Hospital in Qom city, from 3 March to 3 August 2020. COVID infection, be confirmed by using real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) and chest computed tomography (CT) scan, as well.
Results: According to the clinical findings, pure hyperbilirubinemia may consider as rare gastrointestinal (GI) symptom of COVID-19. However, it is possible that the other GI enzymes values fall in to the normal range.
Conclusion: In some infected patients, GI physicians may face hepatic involvement as pure hyperbilirubinemia. At the age of COVID-19 crisis, all GI physicians should be aware of the possible occurrence of hepatic involvement as an important prognosis of COVID pneumonia and it should be exactly addressed in new referred patients to GI clinic.
Export Options
About this article
Cite this article as:
Hormati Ahmad , Ghadir Reza Mohammad , Saeidi Mohammad , Aminnejad Reza , Afifian Mahboubeh and Ahmadpour Sajjad *, Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921191569 . https://dx.doi.org/10.2174/1871526521666210218201601
DOI https://dx.doi.org/10.2174/1871526521666210218201601 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach
Current Pharmaceutical Design A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research
Current Pharmaceutical Design COVID-19: Potential Repurposing Drugs
Infectious Disorders - Drug Targets Death from Alcohol Consumption During the Outbreak of COVID-19
Current Psychiatry Research and Reviews Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes
Current Neurovascular Research Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
Current Pharmaceutical Design Role of Cation-π Interactions in the Structural Stability of Bacterial Adhesins
Protein & Peptide Letters Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors
Medicinal Chemistry Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin- like Main Protease (3CLpro) from Four Different Coronaviruses: An in silico Approach
Coronaviruses An Overview on COVID-19 Pandemic: from Discovery to Treatment
Infectious Disorders - Drug Targets Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation
Current Topics in Medicinal Chemistry Emerging Therapeutic Approaches to COVID-19
Current Pharmaceutical Design Antiviral Activity of Natural and Synthetic Brassinosteroids
Current Medicinal Chemistry - Anti-Infective Agents <i>Nigella Sativa</i>: An Immunity Booster as Pandemic Treatment Solution Against SARS-CoV-2
Coronaviruses Abiding by the World Health Organization Guidelines: A Hobson’s Choice
Coronaviruses Impact of COVID-19 Pandemic on Cardiology Resident Training and Education
New Emirates Medical Journal Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation
Combinatorial Chemistry & High Throughput Screening Antiviral Activity and Molecular Targets of Plant Natural Products Against Avian Influenza Virus
Current Organic Chemistry Quantification of Glycyrrhetic Acid in Human Plasma by LC–MS/MS: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Point of Care Ultrasound in Coronavirus 2019: Helpful or Not?
Current Respiratory Medicine Reviews